# Template Caution Modifications Summary

## Overview
Modified report generation templates to use more cautious language and avoid overstating the strength of genetic associations and disease links.

## Key Changes Made

### 1. Evidence Level Classifications
**Before**: `[Strong/Moderate/Emerging]`
**After**: `[Well-established/Moderate/Emerging/Limited]`

**Rationale**: 
- "Strong" implies high certainty which may not be appropriate for many genetic associations
- "Well-established" is more accurate for associations with solid evidence base
- Added "Limited" category for weaker associations

### 2. Language Softening

#### Executive Summary Template
- **Before**: "most significant PROTEIN MUTATIONS"
- **After**: "PROTEIN MUTATIONS identified"
- **Before**: "Diseases strongly associated with"
- **After**: "Diseases that may be associated with"
- **Before**: "Cascading effects of the protein mutations"
- **After**: "Possible effects of the protein mutations"

#### Risk Assessment Template
- **Before**: "evidence_strength": "[Strong/Moderate/Emerging]"
- **After**: "evidence_strength": "[Well-established/Moderate/Emerging/Limited]"

#### Clinical Implications Template
- **Before**: "Screening for diseases strongly associated with the mutated proteins"
- **After**: "Screening for diseases that may be associated with the mutated proteins"

#### GWAS Analysis Template
- **Before**: "Significant GWAS associations analysis"
- **After**: "Notable GWAS associations analysis"
- **Before**: "most clinically significant associations"
- **After**: "most clinically relevant associations"

### 3. Added Cautionary Requirements

#### Executive Summary
Added requirements to:
- "Include appropriate caveats about the strength and limitations of evidence"
- "Avoid overstating certainty - use qualifying language like 'may be associated with', 'could potentially', 'evidence suggests'"
- "Emphasize the functional impact of protein mutations while acknowledging uncertainty where it exists"

#### Risk Assessment
Added requirements to:
- "Use cautious language - avoid definitive statements about risk levels"
- "Include appropriate caveats about the predictive value of genetic information"
- "Acknowledge that genetic predisposition does not guarantee disease development"
- "Quantify risk based on strength of protein-disease relationships, acknowledging limitations"

#### Clinical Implications
Added requirements to:
- "Use cautious language - recommendations should be presented as considerations rather than definitive requirements"
- "Acknowledge that genetic information should be interpreted in clinical context"
- "Include protein-targeted therapeutic options where available, noting their experimental status if applicable"
- "Base screening on diseases associated with the mutated proteins, with appropriate caveats about predictive value"

## Impact on Report Generation

### More Balanced Language
- Reports will use more measured language when describing genetic associations
- Uncertainty and limitations will be explicitly acknowledged
- Recommendations will be framed as considerations rather than mandates

### Evidence-Based Grading
- Four-tier evidence classification system provides more nuanced assessment
- "Limited" category allows inclusion of weaker associations with appropriate caveats
- "Well-established" reserved for truly robust associations

### Clinical Appropriateness
- Language aligns better with medical practice standards
- Reduces risk of overstating genetic determinism
- Maintains clinical utility while acknowledging uncertainty

## Files Modified

1. **blocks/executive_summary_block.txt**
   - Softened language around "significant" findings
   - Added cautionary requirements
   - Updated evidence level classifications

2. **blocks/risk_assessment_block.txt**
   - Updated evidence strength classifications
   - Added requirements for cautious language
   - Emphasized uncertainty acknowledgment

3. **blocks/clinical_implications_block.txt**
   - Softened screening recommendations
   - Updated evidence level classifications
   - Added clinical context requirements

4. **blocks/literature_evidence_block.txt**
   - Updated evidence strength classifications
   - Modified overall strength assessments

5. **blocks/mutation_profile_block.txt**
   - Updated evidence level classifications

6. **blocks/lifestyle_recommendations_block.txt**
   - Updated evidence level classifications

7. **blocks/gwas_analysis_block.txt**
   - Changed "significant" to "notable"
   - Updated evidence level classifications
   - Softened language around clinical significance

## Recommended Qualifying Language

Templates now encourage use of:
- "may be associated with" instead of "is associated with"
- "could potentially" instead of "will"
- "evidence suggests" instead of "evidence shows"
- "appears to" instead of "is"
- "might contribute to" instead of "causes"

## Benefits

### 1. Medical Accuracy
- Language better reflects the probabilistic nature of genetic associations
- Reduces risk of overstating certainty
- Aligns with evidence-based medicine principles

### 2. Legal/Ethical Compliance
- Reduces liability from overstated claims
- Better informed consent through appropriate caveats
- Meets professional standards for genetic counseling

### 3. Clinical Utility
- Maintains actionable information while acknowledging limitations
- Helps clinicians make appropriate decisions
- Supports shared decision-making with patients

### 4. Scientific Integrity
- Accurately represents the state of genetic knowledge
- Acknowledges gaps and uncertainties
- Promotes appropriate interpretation of genetic data

## Usage Guidelines

When generating reports, the AI will now:
1. Use more cautious language by default
2. Include appropriate caveats about evidence strength
3. Acknowledge uncertainty where it exists
4. Frame recommendations as considerations
5. Emphasize the need for clinical interpretation

This creates more balanced, medically appropriate genetic reports that maintain clinical utility while avoiding overstatement of genetic associations.